These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 1847845

  • 1. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
    Sasaki Y, Shinkai T, Eguchi K, Tamura T, Ohe Y, Ohmori T, Saijo N.
    Cancer Chemother Pharmacol; 1991; 27(4):263-70. PubMed ID: 1847845
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological approach to the platinum compounds].
    Sasaki Y.
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):456-62. PubMed ID: 1313667
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
    Fukuda M, Ohe Y, Kanzawa F, Oka M, Hara K, Saijo N.
    Anticancer Res; 1995 Apr; 15(2):393-8. PubMed ID: 7763011
    [Abstract] [Full Text] [Related]

  • 4. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996 Apr; 16(1):251-6. PubMed ID: 8615617
    [Abstract] [Full Text] [Related]

  • 5. A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity.
    Dmitrovsky E, Seifter EJ, Gazdar AF, Tsai CM, Edison M, Brantley P, Veach SR, Batist G, Ihde DC, Mulshine JL.
    Am J Clin Oncol; 1990 Aug; 13(4):285-9. PubMed ID: 2165737
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of a new platinum compound (glycolate-o,o') diammineplatinum (II) (254-S), against non-small cell lung carcinoma grown in a human tumor clonogenic assay system.
    Kanzawa F, Matsushima Y, Nakano H, Nakagawa K, Takahashi H, Sasaki Y, Saijo N.
    Anticancer Res; 1988 Aug; 8(3):323-7. PubMed ID: 2839098
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of the antitumor activity of newly developed platinum analogs in lung cancer using the colony assay].
    Yonei T, Ohnoshi T, Hiraki S, Ueoka H, Yamashita H, Kozuka A, Moritaka T, Uji H, Kiura K, Mima Y.
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):427-30. PubMed ID: 2539056
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens.
    Yonei T, Ohnoshi T, Hiraki S, Ueoka H, Kiura K, Moritaka T, Shibayama T, Tabata M, Segawa Y, Takigawa N.
    Acta Med Okayama; 1993 Aug; 47(4):233-41. PubMed ID: 8213217
    [Abstract] [Full Text] [Related]

  • 9. Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin.
    Tang CH, Parham C, Shocron E, McMahon G, Patel N.
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1389-400. PubMed ID: 20809122
    [Abstract] [Full Text] [Related]

  • 10. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Alberts DS, Fanta PT, Running KL, Adair LP, Garcia DJ, Liu-Stevens R, Salmon SE.
    Cancer Chemother Pharmacol; 1997 Jun; 39(6):493-7. PubMed ID: 9118460
    [Abstract] [Full Text] [Related]

  • 11. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
    Twentyman PR, Wright KA, Mistry P, Kelland LR, Murrer BA.
    Cancer Res; 1992 Oct 15; 52(20):5674-80. PubMed ID: 1327513
    [Abstract] [Full Text] [Related]

  • 12. Small cell lung cancer: defining a role for emerging platinum drugs.
    Schiller JH.
    Oncology; 2002 Oct 15; 63(2):105-14. PubMed ID: 12239444
    [Abstract] [Full Text] [Related]

  • 13. In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin.
    Takahashi H, Sasaki Y, Saijo N, Sakurai M, Nakano H, Nakagawa K, Hoshi A, Jett JR, Hong WS.
    Cancer Chemother Pharmacol; 1987 Oct 15; 19(3):197-200. PubMed ID: 3034444
    [Abstract] [Full Text] [Related]

  • 14. Review of therapeutic trials of carboplatin in lung cancer.
    Bunn PA.
    Semin Oncol; 1989 Apr 15; 16(2 Suppl 5):27-33. PubMed ID: 2541506
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3- dioxolane]platinum(II), as determined by ex vivo pharmacodynamics.
    Kim DK, Kim HT, Tai JH, Cho YB, Kim TS, Kim KH, Park JG, Hong WS.
    Cancer Chemother Pharmacol; 1995 Apr 15; 37(1-2):1-6. PubMed ID: 7497577
    [Abstract] [Full Text] [Related]

  • 16. In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice.
    Heike Y, Takahashi M, Ohira T, Arioka H, Funayama Y, Nishio K, Ogasawara H, Saijo N.
    Cancer Chemother Pharmacol; 1995 Apr 15; 35(3):200-4. PubMed ID: 7805177
    [Abstract] [Full Text] [Related]

  • 17. Platinum compounds in the treatment of advanced breast cancer.
    Martín M.
    Clin Breast Cancer; 2001 Oct 15; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [Abstract] [Full Text] [Related]

  • 18. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ, Sleijfer S, Meijer C, Kampinga HH, Konings AW, De Vries EG, Mulder NH.
    Br J Cancer; 1995 Dec 15; 72(6):1406-11. PubMed ID: 8519652
    [Abstract] [Full Text] [Related]

  • 19. Levels of glutathione S transferase pi mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin.
    Nakagawa K, Yokota J, Wada M, Sasaki Y, Fujiwara Y, Sakai M, Muramatsu M, Terasaki T, Tsunokawa Y, Terada M.
    Jpn J Cancer Res; 1988 Mar 15; 79(3):301-4. PubMed ID: 2836347
    [Abstract] [Full Text] [Related]

  • 20. [Development of platinum analogues for the treatment of lung cancer].
    Nakai Y.
    Gan To Kagaku Ryoho; 1992 Nov 15; 19(13):2157-62. PubMed ID: 1332625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.